Traditional Chinese medicine composition for treating hepatorenal syndrome due to blood stasis causing water retention

Abstract

The invention belongs to the technical field of medicines, and particularly relates to a traditional Chinese medicine composition for treating hepatorenal syndrome due to blood stasis causing water retention. The composition is prepared from the following traditional Chinese medicinal materials in parts by weight: 4-8 parts of black soybeans, 4-8 parts of lysimachia barystachys bunge, 4-8 parts of aralia undulata, 4-8 parts of blumea balsamifera root, 4-8 parts of broad bean shells, 4-8 parts of shells of sterculia nobilis smith, 4-8 parts of rhodiola dumulosa, 4-8 parts of fruits of rubus hirsutus thunb and 4-8 parts of licorice root. The medicinal materials are combined to achieve the effects of promoting blood circulation, inducing diuresis, tonifying kidneys and nourishing liver. The traditional Chinese medicine composition can be used for effectively improving the clinical symptoms and signs of patients, reducing the level of blood urea nitrogen, creatinine and urine protein, improving the glomerular filtration rate, improving the renal functions, reducing the level of glutamic-pyruvic transaminase and glutamic oxalacetic transaminase and improving liver functions.

Description

technical field [0001] The invention belongs to the technical field of medicine, and in particular relates to a traditional Chinese medicine composition for treating hepatorenal syndrome of blood stasis and water stagnation type. Background technique [0002] Hepatorenal syndrome (HRS) refers to a functional renal failure in patients with severe liver diseases such as cirrhosis and severe viral hepatitis without clear primary renal disease. It was first proposed by Helwig in 1932. At that time, it was used to describe acute renal failure after biliary obstruction surgery. Later, it was used to refer to all diseases involving the liver and kidney at the same time. At present, it often refers to liver cirrhosis, fulminant hepatic failure, severe viral hepatitis, primary Functional renal failure secondary to severe liver disease such as primary or secondary liver cancer. There are no primary and specific organic lesions in the kidneys of patients with hepatorenal syndrome, and...

AI Technical Summary

Problems solved by technology

At present, the pathogenesis of hepatorenal syndrome is not fully understood by Western medicine, and there is no effective treatment for it.